NuVasive® To Participate In Investor Events In May 2015

SAN DIEGO, CA – May 7, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor events in May 2015:

  • Bank of America 2015 Healthcare Conference at the Encore at the Wynn Hotel in Las Vegas, NV on Tuesday, May 12, 2015 at 11:40 a.m. ET / 8:40 a.m. PT; and
  • UBS Global Healthcare Conference at the Sheraton New York Hotel in New York, NY on Tuesday, May 19, 2015 at 1:30 p.m. ET / 10:30 a.m. PT.

A live webcast of each presentation will be available online from the Investor Relations page of the Company’s website at  A replay of each presentation will remain available on the website for 30 days after the applicable live webcast.

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurallyintegrated solutions for the spine.  The Company is the third largest player in the $9.0 billion global spine market.  NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company’s principal procedural solution is its Maximum Access Surgery, or MAS®, platform for lateral spine fusion.  MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

NuVasive cautions you that statements included in this news release or made during the investor events announced herein that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive’s revenue or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating revenue or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at  NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

# # #

Investor/Media Contact:
Stacy Roughan
NuVasive, Inc.
[email protected]

Previous PostNext Post